Eun Ju Choo
Overview
Explore the profile of Eun Ju Choo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shantakumar S, Choo E, Parikh R, Kwon T, Kim H, Vandervoort L, et al.
Hum Vaccin Immunother
. 2025 Mar;
21(1):2469419.
PMID: 40063054
In South Korea, the increasing incidence of herpes zoster (HZ) and aging population warrant consideration of HZ vaccination for older adults. There is a need to understand the HZ vaccine-related...
2.
Beom Park W, Hwang Y, Kwon K, Noh J, Park S, Song J, et al.
Infect Chemother
. 2025 Jan;
56(4):453-460.
PMID: 39762924
The Korean Society of Infectious Diseases has been regularly publishing guidelines for adult immunization since 2007. Following the release of coronavirus disease 2019 (COVID-19) vaccination recommendations in 2023, significant changes...
3.
Choi W, Song J, Kwon K, Lee H, Choo E, Baek J, et al.
Infect Chemother
. 2024 Jul;
56(2):188-203.
PMID: 38960738
The Korean Society of Infectious Diseases has been regularly developing guidelines for adult immunization since 2007. In 2023, the guidelines for the following seven vaccines were revised: influenza, herpes zoster,...
4.
Lovell J, Miura K, Baik Y, Lee C, Lee J, Park Y, et al.
Int J Infect Dis
. 2023 Nov;
138:73-80.
PMID: 37944586
Objective: EuCorVac-19 (ECV-19), an adjuvanted liposome-displayed receptor binding domain (RBD) COVID-19 vaccine, previously reported interim Phase 2 trial results showing induction of neutralizing antibodies 3 weeks after prime-boost immunization. The...
5.
Park S, Lee S, Jung H, Shin J, Moon J, Choo E, et al.
Infect Control Hosp Epidemiol
. 2023 Oct;
45(3):377-379.
PMID: 37870121
In this observational study conducted in 2022, 12.3% of patients who shared a room with a patient positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) also had a positive...
6.
Park S, Kim J, Lee E, Park S, Park J, Yu S, et al.
Infect Control Hosp Epidemiol
. 2023 Oct;
45(2):215-220.
PMID: 37791517
Objective: We investigated gender differences in psychosocial determinants that affect hand hygiene (HH) performance among physicians. Design: The survey included a structured questionnaire with 7 parts: self-assessment of HH execution...
7.
Kim J, Yu S, Jeong Y, Kim J, Jeon M, Kim T, et al.
Antimicrob Resist Infect Control
. 2023 Sep;
12(1):93.
PMID: 37674241
Background: Hand hygiene (HH) is a fundamental component of infection prevention and control in healthcare settings. This study aimed to identify knowledge, attitude, and barriers to HH according to occupational...
8.
Lim S, Kim H, Kim S, Choi S, Kim B, Kim J, et al.
J Korean Med Sci
. 2023 Apr;
38(13):e103.
PMID: 37012688
Background: Although the primary vaccine coverage rate for coronavirus disease 2019 (COVID-19) in South Korea has exceeded 80%, the coronavirus continues to spread, with reports of a rapid decline in...
9.
Jeong H, Baek A, Park S, Kim T, Choo E, Jeon C
Int J Rheum Dis
. 2023 Mar;
26(5):850-861.
PMID: 36967612
Aim: Coronavirus disease 2019 (COVID-19) has been proposed as triggering autoimmunity. The aim of this study was to evaluate the presence and clinical significance of autoantibodies in patients with COVID-19....
10.
Lovell J, Baik Y, Keun Choi S, Lee C, Lee J, Miura K, et al.
BMC Med
. 2022 Nov;
20(1):462.
PMID: 36447243
Background: Numerous vaccine strategies are being advanced to control SARS-CoV-2, the cause of the COVID-19 pandemic. EuCorVac-19 (ECV19) is a recombinant protein nanoparticle vaccine that displays the SARS-CoV-2 receptor-binding domain...